$0.1581
-0.0505-24.21%
AEON Biopharma (AEON) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.33 | $-0.44 | $-0.26 | $-0.43 |
| Actual | $-0.02 | $-0.29 | $-3.72 | $-0.39 |
| Surprise | +93.9% | +34.1% | -1330.8% | +9.30% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.09 | $-0.08 | $-0.09 | $-0.06 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $-0.02 | $-0.33 | 93.9 % |
| Q1 | May 14, 2026 | $-0.29 | $-0.44 | 34.1 % |
| Q4 | Mar 30, 2026 | $-3.72 | $-0.26 | -1330.8 % |
| Q3 | Nov 14, 2025 | $-0.39 | $-0.43 | 9.30 % |